Report Detail
Global Opioids Drugs Market Insights and Forecast to 2026
- RnM4150559 |
- 21 August, 2020 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Opioids Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Opioids Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Opioids Drugs market is segmented into
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
Segment by Application, the Opioids Drugs market is segmented into
Pain Relief
Anesthesia
Other
Regional and Country-level Analysis
The Opioids Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Opioids Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Opioids Drugs Market Share Analysis
Opioids Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Opioids Drugs business, the date to enter into the Opioids Drugs market, Opioids Drugs product introduction, recent developments, etc.
The major vendors covered:
Purdue Pharma
J&J
Teva
Mylan
Depomed
INSYS
Endo
Pfizer
Hikma
Mallinckrodt
Pernix
Egalet
Vistapharm
1 Study Coverage
- 1.1 Opioids Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Opioids Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Opioids Drugs Market Size Growth Rate by Type
- 1.4.2 Oxycodone
- 1.4.3 Hydromorphone
- 1.4.4 Codeine
- 1.4.5 Fentanyl
- 1.4.6 Other
- 1.5 Market by Application
- 1.5.1 Global Opioids Drugs Market Size Growth Rate by Application
- 1.5.2 Pain Relief
- 1.5.3 Anesthesia
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Opioids Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Opioids Drugs Revenue 2015-2026
- 2.1.2 Global Opioids Drugs Sales 2015-2026
- 2.2 Global Opioids Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Opioids Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Opioids Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Opioids Drugs Competitor Landscape by Players
- 3.1 Opioids Drugs Sales by Manufacturers
- 3.1.1 Opioids Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Opioids Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Opioids Drugs Revenue by Manufacturers
- 3.2.1 Opioids Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Opioids Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Opioids Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Opioids Drugs Revenue in 2019
- 3.2.5 Global Opioids Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Opioids Drugs Price by Manufacturers
- 3.4 Opioids Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Opioids Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Opioids Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Opioids Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Opioids Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Opioids Drugs Sales by Type (2015-2020)
- 4.1.2 Global Opioids Drugs Revenue by Type (2015-2020)
- 4.1.3 Opioids Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Opioids Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Opioids Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Opioids Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Opioids Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Opioids Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Opioids Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Opioids Drugs Sales by Application (2015-2020)
- 5.1.2 Global Opioids Drugs Revenue by Application (2015-2020)
- 5.1.3 Opioids Drugs Price by Application (2015-2020)
- 5.2 Opioids Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Opioids Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Opioids Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Opioids Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Opioids Drugs by Country
- 6.1.1 North America Opioids Drugs Sales by Country
- 6.1.2 North America Opioids Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Opioids Drugs Market Facts & Figures by Type
- 6.3 North America Opioids Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Opioids Drugs by Country
- 7.1.1 Europe Opioids Drugs Sales by Country
- 7.1.2 Europe Opioids Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Opioids Drugs Market Facts & Figures by Type
- 7.3 Europe Opioids Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Opioids Drugs by Region
- 8.1.1 Asia Pacific Opioids Drugs Sales by Region
- 8.1.2 Asia Pacific Opioids Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Opioids Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Opioids Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Opioids Drugs by Country
- 9.1.1 Latin America Opioids Drugs Sales by Country
- 9.1.2 Latin America Opioids Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Opioids Drugs Market Facts & Figures by Type
- 9.3 Central & South America Opioids Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Opioids Drugs by Country
- 10.1.1 Middle East and Africa Opioids Drugs Sales by Country
- 10.1.2 Middle East and Africa Opioids Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Opioids Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Opioids Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Purdue Pharma
- 11.1.1 Purdue Pharma Corporation Information
- 11.1.2 Purdue Pharma Description and Business Overview
- 11.1.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Purdue Pharma Opioids Drugs Products Offered
- 11.1.5 Purdue Pharma Related Developments
- 11.2 J&J
- 11.2.1 J&J Corporation Information
- 11.2.2 J&J Description and Business Overview
- 11.2.3 J&J Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 J&J Opioids Drugs Products Offered
- 11.2.5 J&J Related Developments
- 11.3 Teva
- 11.3.1 Teva Corporation Information
- 11.3.2 Teva Description and Business Overview
- 11.3.3 Teva Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Teva Opioids Drugs Products Offered
- 11.3.5 Teva Related Developments
- 11.4 Mylan
- 11.4.1 Mylan Corporation Information
- 11.4.2 Mylan Description and Business Overview
- 11.4.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Mylan Opioids Drugs Products Offered
- 11.4.5 Mylan Related Developments
- 11.5 Depomed
- 11.5.1 Depomed Corporation Information
- 11.5.2 Depomed Description and Business Overview
- 11.5.3 Depomed Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Depomed Opioids Drugs Products Offered
- 11.5.5 Depomed Related Developments
- 11.6 INSYS
- 11.6.1 INSYS Corporation Information
- 11.6.2 INSYS Description and Business Overview
- 11.6.3 INSYS Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 INSYS Opioids Drugs Products Offered
- 11.6.5 INSYS Related Developments
- 11.7 Endo
- 11.7.1 Endo Corporation Information
- 11.7.2 Endo Description and Business Overview
- 11.7.3 Endo Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Endo Opioids Drugs Products Offered
- 11.7.5 Endo Related Developments
- 11.8 Pfizer
- 11.8.1 Pfizer Corporation Information
- 11.8.2 Pfizer Description and Business Overview
- 11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Pfizer Opioids Drugs Products Offered
- 11.8.5 Pfizer Related Developments
- 11.9 Hikma
- 11.9.1 Hikma Corporation Information
- 11.9.2 Hikma Description and Business Overview
- 11.9.3 Hikma Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Hikma Opioids Drugs Products Offered
- 11.9.5 Hikma Related Developments
- 11.10 Mallinckrodt
- 11.10.1 Mallinckrodt Corporation Information
- 11.10.2 Mallinckrodt Description and Business Overview
- 11.10.3 Mallinckrodt Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Mallinckrodt Opioids Drugs Products Offered
- 11.10.5 Mallinckrodt Related Developments
- 11.1 Purdue Pharma
- 11.1.1 Purdue Pharma Corporation Information
- 11.1.2 Purdue Pharma Description and Business Overview
- 11.1.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Purdue Pharma Opioids Drugs Products Offered
- 11.1.5 Purdue Pharma Related Developments
- 11.12 Egalet
- 11.12.1 Egalet Corporation Information
- 11.12.2 Egalet Description and Business Overview
- 11.12.3 Egalet Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Egalet Products Offered
- 11.12.5 Egalet Related Developments
- 11.13 Vistapharm
- 11.13.1 Vistapharm Corporation Information
- 11.13.2 Vistapharm Description and Business Overview
- 11.13.3 Vistapharm Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Vistapharm Products Offered
- 11.13.5 Vistapharm Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Opioids Drugs Market Estimates and Projections by Region
- 12.1.1 Global Opioids Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Opioids Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Opioids Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Opioids Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Opioids Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Opioids Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Opioids Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Opioids Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Opioids Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Opioids Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Opioids Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Opioids Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Opioids Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Opioids Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Opioids Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Opioids Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Opioids Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Opioids Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Opioids Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Opioids Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Opioids Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Opioids Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Opioids Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Opioids Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Opioids Drugs. Industry analysis & Market Report on Opioids Drugs is a syndicated market report, published as Global Opioids Drugs Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Opioids Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
